Cancer Research UK, ONO Pharmaceutical and LifeArc are shortlisted for a Scrip Award

2019-09-17 00:00:00

We are happy to announce that our immunotherapy alliance partnership with LifeArc and Ono Pharmaceutical has been shortlisted as a finalist for the Best Partnership Alliance for the Annual Scrip Awards. The alliance was first formed between Cancer Research UK and LifeArc in 2017 to identify targets for the development of both antibody and small molecule therapeutics. This year the partnership expanded to include Ono Pharmaceutical, bringing additional scientific expertise as well as a multimillion-pound investment from Ono and a further investment from LifeArc.

The Scrip Awards for the last 15 years have sought to applaud the essential role that the pharmaceutical, biotech and other allied industries play in improving healthcare. Our partners continue to pave the way as Mission Therapeutics is also up for Best Partnership Alliances, Artois Pharma shortlisted for the Best Financing Deal and Achilles Therapeutics up for Biotech Company of the Year.

Click here to view the shortlist:



Notes to editors